The appropriate timing of angiography to facilitate revascularization is essential to optimize
outcomes in patents with ST-segment–elevation myocardial infarction and non–ST-segment …

There are an estimated 500,000 ST-segment elevation myocardial infarction (STEMI) events
in the US annually. Despite improvements in care, up to one-third of patients presenting with …

Prompt restoration of blood flow is the primary treatment goal in ST-segment elevation
myocardial infarction to optimize clinical outcomes. The ED plays a critical role in rapid …

We developed a regional strategy to decrease the time to percutaneous coronary
intervention (PCI) for patients with acute ST-segment elevation myocardial infarction …

Although the medical and technologic revolution in the last 3 decades has improved clinical
outcome in patients sustaining acute ST-elevation myocardial infarction (STEMI), residual …

Given the overall superiority of primary PCI over hospitaladministered fibrinolysis, 2 the
former has emerged as the treatment of choice when the facilities and a high-volume …

Background We systematically reviewed trials comparing different reperfusion strategies for
ST‐segment–elevation myocardial infarction and used multivariate network meta‐analysis …

Reperfusion treatment of ST-segment elevation myocardial infarction (STEMI) is one of the
medical interventions with the largest potential for saving human lives, independently of age …

Optimal treatment for ST-segment elevation myocardial infarction depends on early
diagnosis and rapid selection of the appropriate reperfusion strategy. Primary percutaneous …

Despite the wide contemporary availability of pharmacological and mechanical means of
reperfusion, a very significant proportion of ST-segment elevation myocardial infarction …